KBL Merger Co. IV (KBLM) Shareholders Approve CannBioRx Deal
KBL Merger Co. IV (NASDAQ:KBLM) announced in an 8-K filing this afternoon that its shareholders approved its merger with CannBioRx Life Sciences Corp at a special meeting November 5, but also redeemed shares worth most of its trust value. A total of 816,461 shares were redeemed, removing about $9 million from its trust and leavingRead More